Full video transcriptClick to expand
Auto-generated transcript of @titansphysique's video. Quoted here for educational fact-check commentary; original creator retains all rights to the video content.
- 0:00What was where your test never goes back to baseline is if you're an avid bodybuilder who's been in the game for 10 plus years.
- 0:06My test, I think my test will go back to normal. What is it I want to hear too?
- 0:11I don't want to come off of you.
- 0:12And you know that you touched the rest of the lot.
- 0:14I've made that conscious decision to stay on for the rest of my life and that's just something I'm going to have to do.
TRT dosing advice from fitness influencers: hype vs. clinical evidence
Quick answer
Prolonged anabolic-androgenic steroid use suppresses the hypothalamic-pituitary-gonadal axis through negative feedback, potentially resulting in persistent hypogonadism after cessation. The creator correctly identifies that long-term bodybuilders face higher risk of incomplete testosterone recovery, though the absolute framing of 'never goes back' overstates certainty given evidence of variable recovery outcomes. Patients with suspected post-AAS hypogonadism should have serial testosterone, LH, and FSH testing over 6 to 12 months before concluding that endogenous recovery is not possible.
Video review standard
Clinical fact-check snapshot
FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.
Evidence signal
Source-backed review
Regulatory reality
Access rules depend on the compound and patient situation
Safety screen
Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.
This page currently connects to 8 source-backed evidence items through visible references or structured citation data.
PubMed evidence trail
Research sources used to frame this page
For TRT dosing advice from fitness influencers: hype vs. clinical evidence, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.
Cardiovascular Safety of Testosterone-Replacement Therapy
TRAVERSE trial anchor for cardiovascular-safety discussions in appropriately diagnosed men.
PubMed
Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline
Guideline anchor for diagnosis, monitoring, contraindications, and appropriate TRT framing.
PubMed
NAD+ metabolism and its roles in cellular processes during ageing
Core review for NAD+ decline, mitochondrial function, DNA repair, and aging biology.
PubMed
Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women
Human NMN source for metabolic claims while keeping population limits clear.
PubMed
Provider decision path
Use local research to choose a safer review path
Direct answer
TRT dosing advice from fitness influencers: hype vs. clinical evidence is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.
Evidence check
Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.
Safety check
Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.
Next step
When you are ready, the get-started flow can collect the details needed for a prescription review instead of leaving you to guess.
Claim path
Keep researching this testosterone and trt video claims cluster
Best for searchers turning TRT social claims into a safer lab-backed provider discussion.
Page-specific review note
What this exact clip is really saying
This FormBlends review is specific to "TRT dosing advice from fitness influencers: hype vs. clinical evidence" from titansphysique. We read the clip as a TRT social video fact-checks claim about Testosterone, then separate the useful signal from what a short social video cannot prove. The page-specific claim focus is: Prolonged anabolic-androgenic steroid use suppresses the hypothalamic-pituitary-gonadal axis through negative feedback, potentially resulting in persistent hypogonadism after cessation.
The reason this review is not generic is the source wording and the canonical claim label "trt foryou chestbrahlegacy zyzzbrah trtdosage." In this clip, the useful excerpt is: "What was where your test never goes back to baseline is if you're an avid bodybuilder who's been in the game for 10 plus years." That wording changes the review because it points to Testosterone evidence, safety, and patient-fit context, not a one-size-fits-all protocol.
The source trail for this page is checked against Cardiovascular Safety of Testosterone-Replacement Therapy (2023), Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline (2010), and Functional testosterone deficiency in aging men: Clinical impact, diagnostic pathways, and treatment strategies (2026), plus the creator's own wording. Testosterone decisions still need an eligibility review, medication-interaction screen, access check, and quality-control review before anyone treats a social clip as medical advice.
Claim verdict
The useful answer behind this video
This page is built to answer the specific claim behind the clip, then separate what is useful from what still needs clinical context. That makes the URL more than a repost: it gives Google, readers, and AI retrieval systems a concise verdict with source and safety boundaries.
Claim being checked
Prolonged anabolic-androgenic steroid use suppresses the hypothalamic-pituitary-gonadal axis through negative feedback, potentially resulting in persistent hypogonadism after cessation.
FormBlends verdict
Testosterone evidence, safety, and patient-fit context
Evidence strength
Source-backed review with clinical or regulatory citations.
Patient-safe next step
Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.
What to do with this video
Use the clip as a claim to verify, not a treatment plan
What it helps with
- Prolonged anabolic-androgenic steroid use suppresses the hypothalamic-pituitary-gonadal axis through negative feedback, potentially resulting in persistent hypogonadism after cessation. The creator correctly identifies that long-term bodybuilders face higher risk of incomplete testosterone recovery, though the absolute framing of 'never goes back' overstates certainty given evidence of variable recovery outcomes. Patients with suspected post-AAS hypogonadism should have serial testosterone, LH, and FSH testing over 6 to 12 months before concluding that endogenous recovery is not possible.
- Kanayama et al. (2015) found roughly 40% of long-term AAS users had persistent hypogonadism after stopping, meaning 60% showed some degree of recovery.
- The HPG axis suppression works through negative feedback on LH and FSH; recovery depends on duration of use, compounds, age at first use, and whether PCT was used.
What it may miss
- It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
- Compound access, legal status, and product quality still need a separate safety check.
- Social video captions rarely show the full evidence base behind a claim.
Best next step
Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.
Start provider reviewWhat You'll Learn
- Kanayama et al. (2015) found roughly 40% of long-term AAS users had persistent hypogonadism after stopping, meaning 60% showed some degree of recovery.
- The HPG axis suppression works through negative feedback on LH and FSH; recovery depends on duration of use, compounds, age at first use, and whether PCT was used.
- Rahnema et al. (2014, Fertility and Sterility) documented that some men show blunted gonadotropin levels years after AAS cessation, validating the creator's concern but not the absolute framing.
- Serial lab testing of testosterone, LH, and FSH over 6 to 12 months post-cessation is the only evidence-based way to assess actual recovery potential.
- PCT protocols involving clomiphene citrate or hCG have clinical support for stimulating the HPG axis, but should only be initiated under physician supervision.
- Choosing lifelong TRT is a legitimate medical path for confirmed hypogonadism, but it should follow a proper diagnostic workup, not a self-determined assumption that recovery is impossible.
- Younger users who cycle for shorter durations and use PCT have meaningfully better recovery odds than the video's framing suggests for the broader bodybuilding population.
Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team · This is not a transcript. It is our independent review of the video above.
What did @titansphysique actually say?
The creator made a specific claim worth taking seriously: that for "avid bodybuilders" with "10 plus years" in the sport, testosterone levels may never return to baseline after stopping. They then followed it with a personal disclosure, saying their own testosterone "will go back to normal," and concluded that they've made a "conscious decision to stay on for the rest of my life."
So there are actually two separate claims here. One is a general statement about long-term bodybuilders facing permanent suppression. The other is a personal belief that their own recovery is still possible. Those two ideas are in tension with each other, and that tension is worth unpacking.
Does the science back this up?
Partially, yes. The research on long-term anabolic-androgenic steroid (AAS) use and hypothalamic-pituitary-gonadal (HPG) axis recovery is genuinely concerning, and the creator is not wrong to flag it.
A widely cited study by Rahnema et al. (2014, Fertility and Sterility) documented persistent hypogonadism in former AAS users, with some men showing suppressed gonadotropins and testosterone years after cessation. Kanayama et al. (2015, Drug and Alcohol Dependence) found that approximately 40% of long-term AAS users in their cohort had ongoing hypogonadism after stopping. The HPG axis, specifically LH and FSH signaling from the pituitary, can remain blunted for months to years depending on duration of use, compounds used, and individual physiology.
That said, "never goes back" is too absolute. Some men do recover, particularly with post-cycle therapy (PCT) protocols involving clomiphene or hCG. Recovery is variable, not binary.
What did they get wrong (or right)?
They got the core mechanism right. Prolonged exogenous androgen exposure does suppress endogenous testosterone production through negative feedback on the HPG axis. That is not controversial.
What they got wrong, or at least oversimplified, is the framing of "never goes back" as a near-certainty for long-term bodybuilders. The evidence shows a spectrum. Rahnema et al. (2014) noted that recovery potential depends heavily on the duration and type of AAS used, age at first use, and whether PCT was employed. Younger users who start PCT promptly have meaningfully better recovery odds than the framing here implies.
The creator also conflates their own situation with a general rule, then immediately contradicts it by saying their test will go back to normal. That inconsistency suggests they are partly reasoning from personal belief rather than evidence. Deciding to stay on testosterone for life is a legitimate medical decision made between a patient and a physician, but presenting it as inevitable for bodybuilders is not accurate.
What should you actually know?
If you are a long-term AAS user concerned about recovery, here is what the evidence actually supports:
- HPG axis suppression is real and can be prolonged. Kanayama et al. (2015) found median suppression lasting over 3 months post-cessation, with some cases extending years.
- Recovery is not guaranteed, but it is not impossible either. Age, duration of use, and compound selection all matter.
- Bloodwork is the only way to know your actual baseline. Self-reported expectations, like "I think my test will go back to normal," are not a substitute for serial lab testing over 6 to 12 months post-cessation.
- If recovery does not occur, TRT under physician supervision is a legitimate clinical option, not a failure. But that is a medical decision, not a foregone conclusion.
- PCT protocols using clomiphene citrate or hCG have evidence supporting HPG axis stimulation, though results vary. Talk to a licensed provider before starting any protocol.
Interested in GLP-1 or peptide therapy?
Get matched with licensed-provider review to help decide if it is right for you.
About the Creator
titansphysique · TikTok creator
21.5K views on this video
#foryou #chestbrahlegacy #zyzzbrah #trtdosage
Frequently asked questions
Quick answers based on this video and our medical team review.
What does the video say about kanayama et al. (2015) found roughly 40% of long-term aas?
Kanayama et al. (2015) found roughly 40% of long-term AAS users had persistent hypogonadism after stopping, meaning 60% showed some degree of recovery.
What does the video say about the hpg axis suppression works through negative feedback on lh?
The HPG axis suppression works through negative feedback on LH and FSH; recovery depends on duration of use, compounds, age at first use, and whether PCT was used.
What does the video say about rahnema et al. (2014, fertility?
Rahnema et al. (2014, Fertility and Sterility) documented that some men show blunted gonadotropin levels years after AAS cessation, validating the creator's concern but not the absolute framing.
What does the video say about serial lab testing of testosterone, lh,?
Serial lab testing of testosterone, LH, and FSH over 6 to 12 months post-cessation is the only evidence-based way to assess actual recovery potential.
What does the video say about pct protocols involving clomiphene citrate?
PCT protocols involving clomiphene citrate or hCG have clinical support for stimulating the HPG axis, but should only be initiated under physician supervision.
What does the video say about choosing lifelong trt?
Choosing lifelong TRT is a legitimate medical path for confirmed hypogonadism, but it should follow a proper diagnostic workup, not a self-determined assumption that recovery is impossible.
Sources & references
Citations extracted from our medical team's review. Click any citation to search PubMed.
Not medical advice. This video was made by titansphysique, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.